Argenx Se (ARGX) Cash & Current Investments (2015 - 2026)

Argenx Se (ARGX) posted quarterly Cash & Current Investments of $5.2 billion for Q2 2026, down 99.55% year-on-year from $1156.3 billion in Q2 2025, and up 16.76% on a QoQ basis from $4.4 billion in Q4 2025.

Argenx Se (ARGX) Cash & Current Investments (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Cash & Current Investments for 12 consecutive years, with $5.2 billion the latest figure, recorded in Q2 2026.

  • Quarterly Cash & Current Investments fell 99.55% year-over-year to $5.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.2 billion (down 99.55% YoY) and the FY2025 annual result came in at $5.9 billion, up 960.14% from the prior year.
  • Cash & Current Investments rose to $5.2 billion in Q2 2026 per ARGX's latest filing, from $4.4 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for ARGX reached as high as $1156.3 billion in Q2 2025 and fell as low as -$1107.0 billion in Q2 2024.
  • A 5-year average of $8.0 billion and a median of $3.2 billion in 2023 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2024 — Cash & Current Investments tumbled 55532.62% — and 2025, when it surged 204.46%.
  • Year by year, Cash & Current Investments stood at $2.2 billion in 2022, then surged by 45.03% to $3.2 billion in 2023, then advanced by 6.26% to $3.4 billion in 2024, then jumped by 31.4% to $4.4 billion in 2025, then advanced by 16.76% to $5.2 billion in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $5.2 billion, $4.4 billion, and $1156.3 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - 61.40 Mn
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn - -
4 BeOne Medicines 470.64 Bn 465.84 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 122.91 Bn 115.67 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 70.07 Bn 61.31 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.77 Bn 62.77 Bn - -
8 Argenx Se 56.21 Bn 51.02 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.60 Bn 37.60 Bn - -
10 Alnylam Pharmaceuticals 37.34 Bn 34.33 Bn 959.66 Mn 3.01 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.18 Bn
Dec 31, 2025 4.44 Bn
Jun 30, 2025 1,156.35 Bn
Dec 31, 2024 3.38 Bn
Jun 30, 2024 -1,106.97 Bn
Dec 31, 2023 3.18 Bn
Jun 30, 2023 2.00 Bn
Dec 31, 2022 2.19 Bn
Jun 30, 2022 2.60 Bn
Dec 31, 2021 2.34 Bn
Jun 30, 2021 2.73 Bn
Dec 31, 2020 1.85 Bn
Jun 30, 2020 2.20 Bn
Dec 31, 2019 1.52 Bn
Jun 30, 2019 1.07 Bn
Dec 31, 2018 642.45 Mn
Jun 30, 2018 489.03 Mn
Dec 31, 2017 519.23 Mn
Jun 30, 2017 250.29 Mn
Dec 31, 2016 139.60 Mn